258 related articles for article (PubMed ID: 25712839)
1. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
[TBL] [Abstract][Full Text] [Related]
3. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: a retrospective analysis.
Park J; Chung HC; Lee JS; Lee BM; Kim DM; Hwang JC; Jo MW; Noh M; Shin JW
Blood Purif; 2008; 26(5):454-9. PubMed ID: 18810227
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma.
Zhou C; Wang R; Ding Y; Du L; Hou C; Lu D; Hao L; Lv W
Int J Clin Exp Pathol; 2014; 7(5):2579-86. PubMed ID: 24966972
[TBL] [Abstract][Full Text] [Related]
6. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
7. [Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jang BK; Lee SH; Chung WJ; Park KS; Cho KB; Hwang JS; Kim YH; Choi JS; Kwon JH
Korean J Hepatol; 2008 Jun; 14(2):168-77. PubMed ID: 18617764
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
[TBL] [Abstract][Full Text] [Related]
10. Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: a prospective cohort study.
Valette X; Parienti JJ; Plaud B; Lehoux P; Samba D; Hanouz JL
J Crit Care; 2012 Jun; 27(3):322.e1-5. PubMed ID: 22033061
[TBL] [Abstract][Full Text] [Related]
11. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
Boulin M; Adam H; Guiu B; Aho LS; Cercueil JP; Di Martino C; Fagnoni P; Minello A; Jouve JL; Hillon P; Bedenne L; Lepage C
Dig Liver Dis; 2014 Apr; 46(4):358-62. PubMed ID: 24462550
[TBL] [Abstract][Full Text] [Related]
13. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Lin HC; Huo TI
Ann Surg Oncol; 2016 Mar; 23(3):994-1002. PubMed ID: 26487000
[TBL] [Abstract][Full Text] [Related]
14. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Garwood ER; Fidelman N; Hoch SE; Kerlan RK; Yao FY
Liver Transpl; 2013 Feb; 19(2):164-73. PubMed ID: 23008091
[TBL] [Abstract][Full Text] [Related]
15. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
[TBL] [Abstract][Full Text] [Related]
16. [Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jeon SH; Park KS; Kim YH; Shin YS; Kang MK; Jang BK; Chung WJ; Cho KB; Hwang JS
Korean J Gastroenterol; 2007 Sep; 50(3):176-82. PubMed ID: 17885283
[TBL] [Abstract][Full Text] [Related]
17. The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma.
Li JX; Wu H; Huang JW; Zeng Y
J Formos Med Assoc; 2012 Sep; 111(9):510-5. PubMed ID: 23021508
[TBL] [Abstract][Full Text] [Related]
18. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Cho HS; Seo JW; Kang Y; Bae EJ; Kim HJ; Chang SH; Park DJ
Clin Exp Nephrol; 2011 Oct; 15(5):714-719. PubMed ID: 21695415
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.
Park JW; Koh YH; Kim HB; Kim HY; An S; Choi JI; Woo SM; Nam BH
J Hepatol; 2012 Jun; 56(6):1336-42. PubMed ID: 22314421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
